Revolution Medicines (RVMD) cash: $384M
Revolution Medicines held $384M in cash and cash equivalents on Dec 31, 2025, down 29.3% from $543M a year earlier.
From Revolution Medicines's filings with the SEC · Read the filing · RVMD stock page
Revolution Medicines cash by year
#1,034 of 4,171 US companies by cash · See the full ranking
| Year ended | Cash | Change |
|---|---|---|
| Dec 31, 2025 | $384M | -29% |
| Dec 31, 2024 | $543M | -22% |
| Dec 31, 2023 | $696M | +331% |
| Dec 31, 2022 | $161M | +49% |
| Dec 31, 2021 | $108M | – |
Cash of similar companies
Companies in the same industry as Revolution Medicines, by SEC industry code, with the closest cash. Each name opens the same page for that company.
| Company | Cash, latest year | Year ended |
|---|---|---|
| Immunocore Holdings | $468M | Dec 31, 2025 |
| Vor Biopharma | $396M | Dec 31, 2025 |
| Revolution Medicines | $384M | Dec 31, 2025 |
| Kymera Therapeutics | $357M | Dec 31, 2025 |
| Crispr Therapeutics | $348M | Dec 31, 2025 |
| Scholar Rock Holding | $324M | Dec 31, 2025 |
| Taysha Gene Therapies | $320M | Dec 31, 2025 |
Questions and answers
What is Revolution Medicines's cash?
Revolution Medicines held $384M in cash and cash equivalents on Dec 31, 2025, down 29.3% from $543M a year earlier.
Numbers as reported in Revolution Medicines's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology